文献速递炎症性肠病

人工智能实现溃疡性结肠炎组织学缓解或活动及临床结局的预测

Artificial Intelligence Enabled Histological Prediction of Remission or Activity and Clinical Outcomes in Ulcerative Colitis.
PubMed 文献 · Gastroenterology · 2023-03-04

本研究开发并验证了一种人工智能计算机辅助诊断系统,用于评估溃疡性结肠炎活检的组织学缓解或活动并预测预后。系统在535份数字化活检中训练和测试,区分组织学活动/缓解的敏感性和特异性分别为89%和85%(PHRI)、94%和76%(Robarts)、89%和79%(Nancy),并能预测内镜缓解/活动及12个月内的疾病 flare。

要点

  • AI系统区分组织学活动/缓解的敏感性89%、特异性85%(PHRI),94%/76%(Robarts),89%/79%(Nancy)。
  • AI预测内镜缓解/活动的准确率分别为79%(UCEIS)和82%(PICaSSO)。
  • 病理学家评估的PHRI组织学活动/缓解组间疾病 flare 的风险比为3.56,AI评估的PHRI为4.64。

核心结论

  • 开发并验证了一种AI模型,可区分溃疡性结肠炎活检的组织学缓解/活动并预测 flare,有望加速、标准化和增强临床实践及试验中的组织学评估。

研究设计与样本

  • 共纳入535份数字化活检(273例患者),按PHRI、Robarts和Nancy组织学指数分级;卷积神经网络分类器在118份活检子集上训练,42份校准,375份测试;并在154份活检(58例患者)外部队列中验证。

主要发现

  • 系统区分组织学活动/缓解的敏感性和特异性分别为89%和85%(PHRI)、94%和76%(Robarts组织学指数)、89%和79%(Nancy组织学指数)。
  • 模型预测相应内镜缓解/活动的准确率分别为79%(溃疡性结肠炎内镜严重指数UCEIS)和82%(Paddington国际虚拟色素内镜评分PICaSSO)。
  • 根据病理学家评估的PHRI,组织学活动/缓解组间疾病 flare 的风险比为3.56;根据AI评估的PHRI,风险比为4.64。
  • 组织学和结局预测均在外部队列中得到验证。

临床怎么用

  • 原文结论认为该AI模型可加速、标准化和增强实践及试验中的组织学评估。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Microscopic inflammation has significant prognostic value in ulcerative colitis (UC); however, its assessment is complex with high interobserver variability. We aimed to develop and validate an artificial intelligence (AI) computer-aided diagnosis system to evaluate UC biopsies and predict prognosis. METHODS: A total of 535 digitalized biopsies (273 patients) were graded according to the PICaSSO Histologic Remission Index (PHRI), Robarts, and Nancy Histological Index. A convolutional neural network classifier was trained to distinguish remission from activity on a subset of 118 biopsies, calibrated on 42 and tested on 375. The model was additionally tested to predict the corresponding endoscopic assessment and occurrence of flares at 12 months. The system output was compared with human assessment. Diagnostic performance was reported as sensitivity, specificity, prognostic prediction through Kaplan-Meier, and hazard ratios of flares between active and remission groups. We externally validated the model in 154 biopsies (58 patients) with similar characteristics but more histologically active patients. RESULTS: The system distinguished histological activity/remission with sensitivity and specificity of 89% and 85% (PHRI), 94% and 76% (Robarts Histological Index), and 89% and 79% (Nancy Histological Index). The model predicted the corresponding endoscopic remission/activity with 79% and 82% accuracy for UC endoscopic index of severity and Paddington International virtual ChromoendoScopy ScOre, respectively. The hazard ratio for disease flare-up between histological activity/remission groups according to pathologist-assessed PHRI was 3.56, and 4.64 for AI-assessed PHRI. Both histology and outcome prediction were confirmed in the external validation cohort. CONCLUSION: We developed and validated an AI model that distinguishes histologic remission/activity in biopsies of UC and predicts flare-ups. This can expedite, standardize, and enhance histologic assessment in practice and trials.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Iacucci M, Parigi TL, Del Amor R, et al. Artificial Intelligence Enabled Histological Prediction of Remission or Activity and Clinical Outcomes in Ulcerative Colitis. Gastroenterology. 2023. PMID: 36871598. doi:10.1053/j.gastro.2023.02.031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。